Emanuele Bizzi
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications
Multiyear Recurrent Pericarditis Disease Duration: Clinical Outcomes After Cessation of Long-Term Interleukin-1 Pathway Inhibition Provide Insights for Chronic Management.
Journal: Journal of the American Heart Association
Published: July 28, 2026
Recurrent pericarditis in children: evidence, controversies, and emerging perspectives.
Journal: Current opinion in immunology
Published: June 04, 2026
The paradigm shift in corticosteroid therapy for idiopathic pericarditis: from high-dose regimens to precision therapy.
Journal: Clinical and experimental rheumatology
Published: March 31, 2026
Emergency in pediatric rheumatology: a narrative review.
Journal: Frontiers in medicine
Published: March 11, 2026
Recurrent pericarditis in children: Clinical and therapeutic differences from adults.
Journal: International journal of cardiology
Published: February 07, 2026
Probiotic supplementation to mitigate berotralstat gastrointestinal side effects: a multicenter case series from the ITACA network.
Journal: Frontiers in immunology
Published: January 17, 2026
Depemokimab and the twice-yearly regimen: pharmacological implications and therapeutic positioning in severe eosinophilic respiratory diseases.
Journal: Frontiers in immunology
Published: January 08, 2026
The intriguing condition of eosinophilic sialodochitis: insights into an emerging type 2 disorder.
Journal: American journal of otolaryngology
Published: October 23, 2025
Hereditary Angioedema Prophylaxis Therapy: Berotralstat and Lanadelumab Safety Profile.
Journal: Medicina (Kaunas, Lithuania)
Published: September 18, 2025
Experiences of omalizumab treatment in peritoneal dialysis and kidney and liver transplantation.
Journal: Internal and emergency medicine
Published: August 08, 2025
Anti-IL5/IL-5 receptor therapies for eosinophilic granulomatosis with polyangiitis: an updated Systematic Review.
Journal: Frontiers in immunology
Published: March 04, 2025
Assessment of potential drug-drug interactions in patients with hereditary angioedema from the ITACA cohort: simulations from a real-life dataset considering danazol versus berotralstat.
Journal: Frontiers in pharmacology
Published: January 02, 2025
Last Updated: 09/26/2026